Abstract B172: Potent Anti-Tumor Activity of a Selective and Orally Bioavailable Reversible Covalent CDK12 Inhibitor
Molecular Cancer Therapeutics(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined